Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2025-12-24 @ 5:23 PM
NCT ID:
NCT06880250
Eligibility Criteria:
Inclusion Criteria:
* Men and women with a confirmed diagnosis of Fabry disease;
* Prescribed course of enzyme replacement therapy with any drug (FABAGAL, FABRAZIM, REPLAGAL);
* Age 8 - 65 years;
* Signed informed consent of the patient and/or his/her legal representative for participation in the study and processing of personal data.
Exclusion Criteria:
* Renal replacement therapy or kidney transplantation;
* Critical illness unrelated to Fabry disease;
* Pregnancy or breastfeeding;
* Refusal of the patient (or his/her legal representative) from further participation in the study or medical care.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
65 Years
Study:
NCT06880250
Study Brief:
Protocol Section:
NCT06880250